Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Streck

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Digestive Diseases and Sciences|May 14, 2011
Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular diseaseAntonio Tursi, Raymond E Joseph, Paul Streck
Gastroenterology|March 3, 2015
Reply: To PMID 25167986Jeffrey B Raskin, Michael A Kamm, Paul Streck
The American Journal of Gastroenterology|May 9, 2012
Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitisGeert D'Haens, William J Sandborn, Karen Barrett, et al.
European Journal of Clinical Pharmacology|March 11, 2014
Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazineLeo Russo, Gary Schneider, Margarita Hauser Gardiner, et al.
Gastroenterology|July 20, 2014
Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trialsJeffrey B Raskin, Michael A Kamm, M Mazen Jamal, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Digestive Diseases and Sciences|May 14, 2011
Expanding applications: the potential usage of 5-aminosalicylic acid in diverticular diseaseAntonio Tursi, Raymond E Joseph, Paul Streck
Gastroenterology|March 3, 2015
Reply: To PMID 25167986Jeffrey B Raskin, Michael A Kamm, Paul Streck
The American Journal of Gastroenterology|May 9, 2012
Once-daily MMX(®) mesalamine for endoscopic maintenance of remission of ulcerative colitisGeert D'Haens, William J Sandborn, Karen Barrett, et al.
European Journal of Clinical Pharmacology|March 11, 2014
Role of pharmacoepidemiology studies in addressing pharmacovigilance questions: a case example of pancreatitis risk among ulcerative colitis patients using mesalazineLeo Russo, Gary Schneider, Margarita Hauser Gardiner, et al.
Gastroenterology|July 20, 2014
Mesalamine did not prevent recurrent diverticulitis in phase 3 controlled trialsJeffrey B Raskin, Michael A Kamm, M Mazen Jamal, et al.
Pageof 1